SNX2112, a synthetic heat shock protein 90 inhibitor, has potent antitumor activity against HER kinase - Dependent cancers
HSP90 Heat-Shock Proteins
These results suggest that Hsp90 inhibition with SNX-2112 (delivered as a prodrug) may represent a promising therapeutic strategy for tumors whose growth and survival is dependent on Hsp90 clients.
PubMed Central ID
Digital Object Identifier (DOI)
Additional Document Info
has global citation frequency